BIORA THERAPEUTICS INC BIOR 7.25 12.01.25
NOTE 7.250%12/0 · US DOMESTIC · CUSIP 74319FAB3
7
institutional holders
-1 vs Q1 2023
$128.5mprincipal reported held*
$75.6mreported value*
0 new
0 added
0 reduced
0 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 7 |
| Q4 2022 | 7 |
| Q1 2023 | 8 |
| Q2 2023 | 7 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 0 | 0 |
| Q1 2023 | 1 | 1 |
| Q2 2023 | 0 | 0 |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| Athyrium Capital Management, LP 39.23% of their portfolio | 103.5m $60.5m | Unchanged |
| Davidson Kempner Capital Management LP 0.14% of their portfolio | 13.0m $6.8m | Unchanged |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC 0.26% of their portfolio | 7.0m $4.5m | Unchanged |
| SILVERBACK ASSET MANAGEMENT LLC 0.19% of their portfolio | 2.6m $1.4m | Unchanged |
| CAMDEN ASSET MANAGEMENT L P /CA 0.04% of their portfolio | 2.4m $1.3m | Unchanged |
| Context Capital Management, LLC 0.11% of their portfolio | 2.2k $1.2m | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |